Cambridge Cancer Genomics

Cambridge Cancer Genomics is an 18-month-old start-up backed by venture capital, with an award-winning history and international recognition from prestigious programs including Y combinator. We are transforming the way cancer patients are treated, through next generation liquid biopsies and smart genomics. Currently, cancer patients may wait months to know whether their chemotherapy is working. In the interim, these patients suffer the side effects. Using simple blood samples, CCG shortens the time required to know whether treatment is working, giving the clinician more time to alter ineffective treatments and reduce unnecessary side effects. Visit http://ccg.ai for more details. We are expanding our team in Cambridge, UK, offering a fantastic opportunity for dedicated individuals who are comfortable in a high-work high-reward environment, and who are enthusiastic for a dynamic and varied role. We are looking for people who fit well into our team and company culture, and who like to overcome challenges and drive the business forward. In exchange, we offer a competitive salary with performance related bonuses and stock options, alongside excellent career development opportunities in a fast-growing start-up with a chance to truly impact how cancer is treated. To apply, please send your CV to [email protected]

CCG is also backed by Pi Campus, Y Combinator, Endure Capital